Suppr超能文献

药物性肺疾病患者血清热休克蛋白 47 水平。

Serum heat shock protein 47 levels in patients with drug-induced lung disease.

机构信息

Second Department of Internal Medicine, Nagasaki University School of Medicine, Nagasaki, Japan.

出版信息

Respir Res. 2013 Nov 20;14(1):133. doi: 10.1186/1465-9921-14-133.

Abstract

BACKGROUND

Heat shock protein (HSP) 47 is a collagen-specific molecular chaperone that is required for molecular maturation of various types of collagens. We recently reported that HSP47 serum levels were markedly higher in patients with acute exacerbations of idiopathic pulmonary fibrosis (IPF) when compared with patients with stable IPF, suggesting that serum HSP47 levels correlate with interstitial pneumonia activity. The aim of this study was to evaluate serum HSP47 levels in patients with drug-induced lung disease (DILD).

METHODS

Findings from high-resolution computed tomographic chest scans of 47 patients with DILD were classified into one of four predominant patterns: organizing pneumonia (OP) (n = 4), nonspecific interstitial pneumonia (NSIP) (n = 24), hypersensitivity pneumonitis (HP) (n = 11), and diffuse alveolar damage (DAD) (n = 8). Serum levels of HSP47, Krebs von den Lungen-6 (KL-6), surfactant protein (SP)-A, and SP-D were measured in these patients.

RESULTS

The PaO2/fraction of inspired oxygen (FiO2) (P/F) ratios were significantly lower and the alveolar-arterial difference of oxygen (A-a DO2) was significantly higher in the DAD group than in the other groups. Patients with DAD had the worst outcomes among the different subgroups. Patients in the DAD group had significantly higher serum HSP47 levels than those in other groups. Receiver operating characteristic curves revealed that HSP47 was superior to KL-6, SP-A, and SP-D for discriminating between the DAD group and the other groups. The cut-off level for HSP47 that resulted in the highest diagnostic accuracy was 1711.5 pg/mL. The sensitivity, specificity, and diagnostic accuracy were 87.5%, 97.4%, and 95.7%, respectively. Serum levels of HSP47 in the group of patients requiring glucocorticoids were significantly higher than those in patients who experienced clinical improvement without glucocorticoid administration. Serum HSP47 levels also significantly correlated with various respiratory parameters.

CONCLUSION

This study demonstrated that serum HSP47 levels were elevated in patients with DILD with a DAD pattern who had the worst outcomes among the different subgroups, and that this was correlated with P/F ratio and A-a DO2.

摘要

背景

热休克蛋白 47(HSP47)是一种胶原特异性分子伴侣,是各种类型胶原分子成熟所必需的。我们最近报道,与稳定型特发性肺纤维化(IPF)患者相比,特发性肺纤维化急性加重(AE-IPF)患者的血清 HSP47 水平明显升高,提示血清 HSP47 水平与间质性肺炎活动度相关。本研究旨在评估药物性肺疾病(DILD)患者的血清 HSP47 水平。

方法

47 例 DILD 患者的高分辨率 CT 胸部扫描结果分为以下四种主要模式之一:机化性肺炎(OP)(n = 4)、非特异性间质性肺炎(NSIP)(n = 24)、过敏性肺炎(HP)(n = 11)和弥漫性肺泡损伤(DAD)(n = 8)。检测这些患者的血清 HSP47、KL-6、表面活性蛋白(SP)-A 和 SP-D 水平。

结果

DAD 组的 PaO2/吸入氧分数(FiO2)(P/F)比值明显较低,肺泡-动脉氧差(A-a DO2)明显较高。不同亚组中,DAD 组患者的预后最差。DAD 组患者的血清 HSP47 水平明显高于其他组。受试者工作特征曲线显示,HSP47 对 DAD 组与其他组的鉴别优于 KL-6、SP-A 和 SP-D。HSP47 的最佳截断值为 1711.5 pg/mL,其诊断的灵敏度、特异性和准确性分别为 87.5%、97.4%和 95.7%。需要糖皮质激素治疗的患者的 HSP47 水平明显高于未接受糖皮质激素治疗但临床改善的患者。HSP47 水平也与各种呼吸参数显著相关。

结论

本研究表明,DILD 伴 DAD 模式的患者血清 HSP47 水平升高,在不同亚组中预后最差,与 P/F 比值和 A-a DO2 相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d70/4176100/1796f32d5441/1465-9921-14-133-1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验